Thymic carcinoma medical therapy: Difference between revisions
Jump to navigation
Jump to search
No edit summary |
No edit summary |
||
Line 4: | Line 4: | ||
==Overview== | ==Overview== | ||
The predominant therapy for thymic carcinoma is surgical resection. Adjunctive cisplatin-basedchemotherapy may be required. | |||
==Medical Therapy== | ==Medical Therapy== | ||
Treatment options include the following: | |||
Surgery | |||
Radiation | |||
Multimodality approach, such as: | |||
Surgical resection | |||
Radiation therapy | |||
Cisplatin-based chemotherapy | |||
==References== | ==References== |
Revision as of 16:05, 4 January 2016
Thymic Carcinoma Microchapters |
Diagnosis |
---|
Case Studies |
Thymic carcinoma medical therapy On the Web |
American Roentgen Ray Society Images of Thymic carcinoma medical therapy |
Risk calculators and risk factors for Thymic carcinoma medical therapy |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Alejandro Lemor, M.D. [2]
Overview
The predominant therapy for thymic carcinoma is surgical resection. Adjunctive cisplatin-basedchemotherapy may be required.
Medical Therapy
Treatment options include the following: Surgery Radiation Multimodality approach, such as: Surgical resection Radiation therapy Cisplatin-based chemotherapy